Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHO-IN Trial: Dantrolene in Chronic Heart Failure with Reduced Ejection Fraction
jRCTs061180059Recruiting
- Start
- Dec 2017
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic heart failure (CHF), heart failure with reduced ejection fraction (HFrEF) and ventricular arrhythmia (VA) comparing Dantrolene with Placebo (2 arms). Primary endpoint: Primary composite endpoint. Started Dec 2017; status: recruiting.
02
Drugs
dantrolene
03
Conditions
chronic heart failure (CHF)heart failure with reduced ejection fraction (HFrEF)ventricular arrhythmia (VA)
Beyond the preview
Go deeper on jRCTs061180059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180059.